Jubilant Pharmova Limited Overview
Pro stress-test →Jubilant Pharmova is an integrated pharmaceutical company operating in India, the Americas, Europe, and internationally across six segments: Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing for Sterile Injectables, Generics, Contract Research Development and Manufacturing, and Proprietary Novel Drugs. The company targets multiple healthcare sectors including pharmaceutical companies, biotech firms, allergists, and hospitals.
Strategic Profile
Pro stress-test →The company holds the second largest commercial radio pharmacy network in the US and is the second largest in the allergenic extract market in the US. Radiopharma contributes approximately 44% of revenue and the company ranks as the #3 radiopharmaceutical manufacturer in the US, positioning it as a significant player in specialty pharmaceuticals and contract services.
Competitive Landscape
Pro stress-test →In the US market, Jubilant Pharmova is the second largest radiopharmaceutical company by network size and the second largest allergenic extract manufacturer. Primary competitors include larger integrated pharma companies like Lantheus Medical, Novartis, and Allergan. The contract manufacturing segment faces competition from larger CDMOs like Lonza and Recro Pharma.
Industry Context
Jubilant Pharmova Limited operates in Pharmaceuticals & Biotechnology - Specialty Pharma & Contract Manufacturing.
Key facts
Founded: 1978 · Headquarters: Noida, India · Employees: 174,012 · Market cap: ₹13,529 Cr ($1.6B USD approx)